Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection history

Researchers evaluated distinct immune responses to mRNA and vector-based COVID-19 vaccines and natural SARS-CoV-2 infections.

Pollution and Antibiotic Resistance; Troponin and Mortality

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

August 13, 2023

Anixa expands cancer vaccine collaboration with Cleveland Clinic

Cleveland Clinic is undertaking a Phase I clinical trial targeting triple-negative breast cancer. Credit: Tatiana from Pixabay. Anixa Biosciences has expanded its partnership with US

May 9, 2024

Bristol Myers drops another CytomX program

Bristol Myers Squibb dropped another CTLA-4 program from its decade-long research collaboration with CytomX after the big pharma reviewed its portfolio. CytomX announced the change

March 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.